Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in Huizhou ForYou Medical Devices, a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading healthcare-focused private equity firms, will remain the company's majority shareholder.
The investment reflects Novo Holdings' conviction in the long-term growth of advanced wound care, increasing global demand for specialised healthcare manufacturing, and China's important role in delivering high-quality medical technologies to healthcare companies around the world.
Headquartered in Huizhou, Guangdong Province, ForYou Medical is a development and manufacturing partner with a comprehensive portfolio of advanced wound care technologies and products.
Since its founding in 2005, continuous innovation has been at the core of the company's growth, driving the development of an integrated platform spanning polymer materials and biomaterial research, product development, regulatory affairs and large-scale manufacturing.
Advanced wound care is a structurally growing healthcare segment, supported by ageing populations, increasing prevalence of chronic wounds and continued adoption of advanced treatment solutions. As healthcare companies increasingly partner with specialist manufacturers to accelerate innovation, broaden product portfolios and improve operational efficiency, demand for high-quality CDMO partners continues to grow.
